Search hospitals > Wyoming > Sheridan
Welch Cancer Center
Claim this profileSheridan, Wyoming 82801
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Adenocarcinoma
418 reported clinical trials
2 medical researchers
Summary
Welch Cancer Center is a medical facility located in Sheridan, Wyoming. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Adenocarcinoma and other specialties. Welch Cancer Center is involved with conducting 418 clinical trials across 501 conditions. There are 2 research doctors associated with this hospital, such as John M. Schallenkamp and Benjamin T. Marchello.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderER positive
HER2 negative
Stage IV
Top PIs
John M. SchallenkampBenefis Healthcare- Sletten Cancer Institute4 years of reported clinical research
Expert in Cancer
Expert in Lung Cancer
184 reported clinical trials
257 drugs studied
Benjamin T. MarchelloKalispell Regional Medical Center9 years of reported clinical research
Studies Breast Cancer
Studies Ovarian Cancer
6 reported clinical trials
20 drugs studied
Clinical Trials running at Welch Cancer Center
Breast Cancer
Bladder Cancer
Non-Small Cell Lung Cancer
Cancer
Lung Cancer
Bladder Carcinoma
Pancreatic Cancer
Melanoma
Squamous Cell Carcinoma
Cutaneous Melanoma
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Shorter Chemo-Immunotherapy Without Anthracyclines
for Breast Cancer
This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Welch Cancer Center?
Welch Cancer Center is a medical facility located in Sheridan, Wyoming. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Adenocarcinoma and other specialties. Welch Cancer Center is involved with conducting 418 clinical trials across 501 conditions. There are 2 research doctors associated with this hospital, such as John M. Schallenkamp and Benjamin T. Marchello.
Where is Welch Cancer Center located?
The Welch Cancer Center is located at 1585 W 5th St, Sheridan, WY.
Who should I call to ask about financial aid or insurance network?
For financial assistance or emergencies at Welch Cancer Center, please call (304) 436-8461. For financial counseling, contact (716) 845-4782. For insurance inquiries, call (304) 436-8461 or visit our website for detailed contact information.
What insurance does Welch Cancer Center accept?
The Welch Cancer Center in Sheridan, Wyoming, accepts a broad range of insurance plans, including commercial, Medicare, Medicare Part C, some Medicaid, U.S. Department of Veterans Affairs, and TRICARE plans. For specific insurance plan acceptance and coverage details, contacting the Welch Cancer Center directly is recommended.
What awards or recognition has Welch Cancer Center received?
The Welch Cancer Center, located at Sheridan Memorial Hospital in Sheridan, Wyoming, is celebrated for being named one of the Top 100 Rural & Community Hospitals for nine consecutive years by The Chartis Center for Rural Health. Leadership at the center is also noteworthy, with Amy being recognized as one of Wyoming's top "Women of Influence" in healthcare for her dedication to expanding local oncology programs.